Scott K Kuwada Selected Research

Scott K Kuwada Research Topics

Disease

11	Neoplasms (Cancer) 10/2020 - 01/2004
5	Colonic Neoplasms (Colon Cancer) 04/2012 - 12/2002
4	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 05/2005
3	Adenoma (Adenomas) 01/2018 - 10/2008
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2018 - 01/2004
2	Polyps 01/2018 - 03/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012 - 03/2012
2	Peritoneal Neoplasms 04/2012 - 03/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2011 - 02/2007
1	Hemorrhage 06/2023
1	Ulcer 06/2023
1	Crohn Disease (Crohn's Disease) 06/2023
1	Fibrosis (Cirrhosis) 01/2020
1	Liver Diseases (Liver Disease) 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Exanthema (Rash) 03/2016
1	Acne Vulgaris 03/2016
1	Liver Neoplasms (Liver Cancer) 07/2013
1	Ovarian Neoplasms (Ovarian Cancer) 03/2012
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 09/2011
1	Intestinal Polyps 09/2011
1	Adenomatous Polyps 10/2008
1	Macular Degeneration (Age-Related Maculopathy) 02/2007
1	Hyperplasia 11/2006
1	Necrosis 03/2004
1	Neoplasm Metastasis (Metastasis) 12/2002

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2012 - 01/2004
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 03/2016
2	SaltsIBA 01/2018 - 03/2016
2	Sulindac (Copal)FDA LinkGeneric 01/2018 - 03/2016
2	Phosphotransferases (Kinase)IBA 06/2012 - 09/2007
2	LigandsIBA 04/2012 - 03/2004
2	BAY 11-7085IBA 04/2012 - 03/2012
2	ErbB Receptors (EGF Receptor)IBA 09/2007 - 03/2004
2	Tyrosine (L-Tyrosine)FDA Link 09/2007 - 03/2004
1	MicroRNAs (MicroRNA)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Pioglitazone (Actos)FDA Link 01/2020
1	Vitamin E FDA LinkGeneric 01/2020
1	AcrylonitrileIBA 02/2015
1	Protein Isoforms (Isoforms)IBA 06/2012
1	Histones (Histone)IBA 06/2012
1	ChromatinIBA 06/2012
1	macroH2A histoneIBA 06/2012
1	Transcription Factors (Transcription Factor)IBA 06/2012
1	Death Domain ReceptorsIBA 04/2012
1	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 04/2012
1	MTOR InhibitorsIBA 09/2011
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2011
1	Everolimus FDA Link 09/2011
1	AlkaloidsIBA 07/2009
1	Antineoplastic Agents (Antineoplastics)IBA 07/2009
1	naamidine AIBA 07/2009
1	Caspase 3 (Caspase-3)IBA 07/2009
1	Calcibiotic Root Canal SealerIBA 10/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2007
1	Monoclonal AntibodiesIBA 09/2007
1	Cetuximab (Erbitux)FDA Link 09/2007
1	Bevacizumab (Avastin)FDA Link 09/2007
1	volociximabIBA 02/2007
1	Integrin beta1IBA 02/2007
1	IntegrinsIBA 11/2006
1	Integrin alpha5IBA 05/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2004
1	AntibodiesIBA 03/2004
1	Trastuzumab (Herceptin)FDA Link 03/2004
1	NF-kappa B (NF-kB)IBA 12/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 03/2004
2	Chemoprevention 03/2016 - 09/2011
1	Operative Surgical Procedures 06/2023
1	Surgical Instruments (Clip) 06/2023
1	Restorative Proctocolectomy 01/2018
1	Liver Transplantation 07/2013
1	Adjuvant Chemotherapy 09/2007